{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:18:35Z","timestamp":1791361115700,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FAPESP Young Investigator","award":["2012\/20911-5"],"award-info":[{"award-number":["2012\/20911-5"]}]},{"name":"Brain and Behavior (NARSAD) Young Investigator","award":["2013\/20493"],"award-info":[{"award-number":["2013\/20493"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pnpbp.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T10:44:58Z","timestamp":1528541098000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression"],"prefix":"10.1016","volume":"86","author":[{"given":"Andr\u00e9 R.","family":"Brunoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Leandro Marciano","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Lucio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Andrade","family":"Lotufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Martins","family":"Bense\u00f1or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2018.06.003_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"MINI international neuropsychiatric interview (MINI): validation of a short structured diagnostic psychiatric interview","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"9","key":"10.1016\/j.pnpbp.2018.06.003_bb0010","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.clinph.2017.06.001","article-title":"Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines","volume":"128","author":"Antal","year":"2017","journal-title":"Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"issue":"5","key":"10.1016\/j.pnpbp.2018.06.003_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.brs.2016.06.004","article-title":"Safety of transcranial direct current stimulation: evidence based update 2016","volume":"9","author":"Bikson","year":"2016","journal-title":"Brain Stimulation"},{"issue":"8","key":"10.1016\/j.pnpbp.2018.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.06.003_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brs.2011.03.002","article-title":"Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions","volume":"5","author":"Brunoni","year":"2012","journal-title":"Brain Stimulation"},{"issue":"4","key":"10.1016\/j.pnpbp.2018.06.003_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/2013.jamapsychiatry.32","article-title":"The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial","volume":"70","author":"Brunoni","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0040","first-page":"91","article-title":"Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis","volume":"56C","author":"Brunoni","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0045","doi-asserted-by":"crossref","unstructured":"Brunoni, A.R., Machado-Vieira, R., Zarate, C.A., Jr., Vieira, E.L., Vanderhasselt, M.A., Nitsche, M.A., Valiengo, L., Bensenor, I.M., Lotufo, P.A., Gattaz, W.F., Teixeira, A.L., 2014b. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology.","DOI":"10.1016\/j.euroneuro.2014.03.006"},{"issue":"7","key":"10.1016\/j.pnpbp.2018.06.003_bb0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00213-013-3322-3","article-title":"Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial","volume":"231","author":"Brunoni","year":"2014","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2018.06.003_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/15622975.2014.958101","article-title":"BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis","volume":"16","author":"Brunoni","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2015.07.006","article-title":"Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial","volume":"185","author":"Brunoni","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.06.003_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/1516-3180.2014.00351712","article-title":"The escitalopram versus electric current therapy for treating depression clinical study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial","volume":"133","author":"Brunoni","year":"2015","journal-title":"Sao Paulo Med. J."},{"issue":"26","key":"10.1016\/j.pnpbp.2018.06.003_bb0070","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1056\/NEJMoa1612999","article-title":"Trial of electrical direct-current therapy versus escitalopram for depression","volume":"376","author":"Brunoni","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0075","first-page":"925","article-title":"Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review","volume":"11","author":"Chen","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"8","key":"10.1016\/j.pnpbp.2018.06.003_bb0080","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neubiorev.2009.07.014","article-title":"A critical review of human endotoxin administration as an experimental paradigm of depression","volume":"34","author":"Dellagioia","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2011.09.007","article-title":"Circulating glial-derived neurotrophic factor is reduced in late-life depression","volume":"46","author":"Diniz","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.pnpbp.2018.06.003_bb0100","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2018.06.003_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","article-title":"The new field of 'precision psychiatry'","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/mp.2014.163","article-title":"The organization of the stress system and its dysregulation in depressive illness","volume":"20","author":"Gold","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2018.06.003_bb0125","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","article-title":"A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity","volume":"26","author":"Hiles","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.psyneuen.2018.02.006","article-title":"Changes in pro-inflammatory cytokine levels and late-life depression: a two year population based longitudinal study","volume":"90","author":"Kim","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0135","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.pnpbp.2018.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"Kohler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2018.06.003_bb0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"Kohler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.pnpbp.2018.06.003_bb0150","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"7215","key":"10.1016\/j.pnpbp.2018.06.003_bb0155","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pnpbp.2018.06.003_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/abn0000158","article-title":"Cross-species evidence for the role of interleukin-33 in depression risk","volume":"125","author":"Kudinova","year":"2016","journal-title":"J. Abnorm. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinph.2016.10.087","article-title":"Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)","volume":"128","author":"Lefaucheur","year":"2017","journal-title":"Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2018.06.003_bb0170","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpsychires.2015.02.004","article-title":"Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study","volume":"63","author":"Lin","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2018.06.003_bb0180","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/1871527313666141130204031","article-title":"Towards a \"metabolic\" subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction","volume":"13","author":"Liu","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.pnpbp.2018.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.psyneuen.2013.02.009","article-title":"NGF serum levels variations in major depressed patients receiving duloxetine","volume":"38","author":"Martino","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.06.021","article-title":"Safety and acceptability of transcranial direct current stimulation for the acute treatment of major depressive episodes: analysis of individual patient data","volume":"221","author":"Moffa","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2018.06.003_bb0195","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2018.06.003_bb0200","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jad.2013.03.015","article-title":"Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression","volume":"150","author":"Palm","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2018.06.003_bb0205","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.euroneuro.2017.04.001","article-title":"Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation","volume":"27","author":"Pariante","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.06.003_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.pnpbp.2018.06.003_bb0215","article-title":"Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant\/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy","volume":"5","author":"Rivera-Rivera","year":"2014","journal-title":"J. Clin. Cell Immunol."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.06.003_bb0220","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.brs.2015.01.401","article-title":"The pursuit of DLPFC: non-neuronavigated methods to target the left dorsolateral prefrontal cortex with symmetric bicephalic transcranial direct current stimulation (tDCS)","volume":"8","author":"Seibt","year":"2015","journal-title":"Brain Stimulation"},{"key":"10.1016\/j.pnpbp.2018.06.003_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618302732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618302732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:46:41Z","timestamp":1759520801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618302732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"alternative-id":["S0278584618302732"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.06.003","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}